Clinical Trial Update: A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) [Phase 2]

View source ↗

Summary

This Phase II randomized trial evaluated the safety, tolerability, and bioactivity of repeated intravitreal iCo-007 injections as monotherapy or with ranibizuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)
• iCo-007

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetic Macular Edema | Phase 2 | Status: TERMINATED | Results posted: 2017-08-30